http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-7511361-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a1b1b9a1612ba7721b7041aa9185512
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77cee83b5b56130766d803f90fc6eeee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5dfc0b033ac4c841466d97a5f28ea32b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C301-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-38
filingDate 1975-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7c96f06ed3471f243aba40c782acf4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd42efe02fbb5c7c681f56711520de81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae45ac64a08f0e5af858865b348e8cae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a32954546565b6e76ebccebd2a5785f
publicationDate 1977-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SE-7511361-L
titleOfInvention OMEGA (ARYL SULFAMID) ALKYLAMINES
abstract omega -(Arylsulfonamido)-alkylamines having the formula R'-SO2NH(CH2)nR I wherein R represents an amino group which can be acylated; R' represents phenyl or naphthyl which can be substituted by halogen or lower alkyl; and n represents an integer from 5 - 8 are effective in inhibiting blood platelet aggregation.
priorityDate 1975-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 29.